New analgesics designed by molecular topology

Quantitative Structure-Activity Relationships

Volumn 15, Issue 3, 1996, Pages 201-207

  Garcia Domenech R ^a   Garcia March F J ^a   Soler, R M ^a   Galvez, J ^a   Anton Fos G M ^a   De Julian Ortiz J V ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Analgesic activity; Linear discriminant analysis; Molecular connectivity

Indexed keywords

DESIGN; DISCRIMINANT ANALYSIS;

4-BENZOYL-3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; ACETYLSALICYLIC ACIDS; ANALGESIC ACTIVITY; ANALGESIC DRUGS; CONNECTIVITY FUNCTION; DESIGN METHOD; LINEAR DISCRIMINANT ANALYZE; MOLECULAR CONNECTIVITY; MOLECULAR TOPOLOGIES; TOPOLOGICAL DESCRIPTORS;

TOPOLOGY;

1 (4 CHLOROPHENYL)PROPANOL; 2 (1 PROPENYL)PHENOL; 2,4 DIMETHYLACETOPHENONE; 4 BENZOYL 3 METHYL 1 PHENYL 2 PYRAZOLIN 5 ONE; 4 CHLOROBENZOHYDRAZIDE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIPOLE; DRUG DESIGN; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0029957335     PISSN: 09318771     EISSN: None     Source Type: Journal    
DOI: 10.1002/qsar.19960150304     Document Type: Article

References (20)

1. Darvas, F., Erdos, I., Teglas, G., QSAR in Drug Design and Toxicology. Elsevier, Amsterdam, (1987).
2. Gajewski, J.J., Gilbert, K.E., Mckelvey, J., Advances in molecular modelling. Editor Liotta, D., JAI Press, Greenwich, CT, vol 2. p. 65 (1990).
3. Kier, L.B., Hall, L.H., Molecular Connectivity in Structure-Activity Analysis: Research Studies Press. Letchworth, England, pp 225-246 (1986).
4. García, R., Gálvez. J., Moliner, R., García, F., Drug Invest., 3(5), 344-350 (1991).
5. Soler, R M., García, F., Antón, G., García, R., Perez, F., Gálvez, J., J. Chromatogr. 607, 91-95, (1992).
6. Mun̄oz, C., Julian-Ortiz, J.V. de, Gimeno, C., Catalán, V., Gálvez, J., Rev. Esp Quimioier, 7, 279-280 (1994).
7. Antón-Fos, G.M., García-Domenech, R., Perez-Gimenez, F., Peris-Ribera, J.E., García-March, F.J and Salabert-Salvador, M.T., Arzneim.-Forsch/Drug Res 44(11), 821-826 (1994).
8. Gálvez, J., García, R., Julian-Ortiz, J.V de, Soler, R., J. Chem. Inf. Comput. Sci. 34, No 5, 1198-1203 (1994).
9. Gálvez, J., García, R., Julian-Ortiz, J.V. de, Soler, R., J. Chem. Inf. Comput. Sci. 35, 2, 272-284 (1995).
10. Flower, R.J., Biochem. Pharmacol., 23, 1439-1450 (1974).
11. Kier, L.B., Hall, L.H., Molecular Connectivity in Chemistry and Drug Research. Academic Press, London, pp 46-79 (1976).
12. Gálvez, J., García, R., Salabert M.T. and Soler R., J. Chem. Inf. Comput. Sci 34, No. 3, 520-525 (1994).
13. Moliner R., Garcia F., Gálvez, J., García R. and Serrano C., An. R., Acad. Farm., 57, 287-298 (1991).
14. Randić, M., J. Chem. Inf. Comput. Sci. 31, 311-320 (1991).
15. Gálvez. J.: García-Domenech, R., Bernai, J.M., García-March, F., An. R. Acad. Farm., 57, 533-546 (1991).
16. Witkin, L.B., Huebner, C.F., Galdi, F., et. al., J. Pharmacol. Exp Ther. 133, 400 (1961).
17. Nakamura H., Shimizu M., Arch. Int. Pharmacodyn. Ther, 282, 16-25 (1986).
18. Miller L.C., Tainter ML., Proc. Soc. Exp. Biol. Med., 57, 261-264 (1944).
19. a ed., Ed. El Ateneo. Buenos Aires, pp 1303-1366 (1986).
20. Batt, D., Maynard J., Petraitis J., Shaw, J., Galbraith W. and Harris R., J. Med. Chem., 33, 360-370 (1990).